eNeuro, 2018 · DOI: https://doi.org/10.1523/ENEURO.0303-18.2018 · Published: October 22, 2018
Following spinal cord injury (SCI), the body's natural ability to recover is limited. This is partly due to a protein called Nogo receptor-1 (NgR1), which inhibits the regrowth of nerve fibers. LOTUS, a substance that blocks NgR1, can help overcome this inhibition. This study used a clinically relevant spinal cord injury model in mice to test the therapeutic effects of LOTUS. The results showed that LOTUS promoted the regeneration of specific nerve tracts and protected nerve cells from dying. Overall, this research suggests that LOTUS could be a beneficial treatment for spinal cord injury. By promoting nerve regeneration and protecting nerve cells, LOTUS may help improve motor function and overall recovery.
LOTUS, with its strong inhibitory action against NgR1, may represent a therapeutic strategy for SCI by promoting endogenous restoration and locomotor improvement.
The study utilized a contusive SCI model, which is more clinically relevant than transection models, enhancing the potential for translation to human treatments.
LOTUS pan-neuronal overexpression potentially improves nerve conduction, as indicated by shorter MEP latency and larger MEP amplitude.